Topics

Companies Related to "Scotland provide year cystic fibrosis drug" [Most Relevant Company Matches] - Page: 2 RSS

09:44 EST 13th November 2019 | BioPortfolio

Here are the most relevant search results for "Scotland provide year cystic fibrosis drug" found in our extensive corporate database of over 50,000 company records.

Showing "Scotland provide year cystic fibrosis drug" Companies 26–50 of 8,900+

Relevant

ELITechGroup Biomedical Systems

ELITechGroup Biomedical Systems (EBS) is the world leader for laboratory diagnosis of cystic fibrosis with the proven products for sweat stimulation, collection, and analysis. The company is also a key player in supporting global laboratories with the world’s most advanced cytocentrifuge rotor, slide stainers, and osmometers.


Blade Therapeutics

Blade Therapeutics is a private biopharmaceutical company advancing novel anti-fibrotic therapies to meet important patient needs. Blade has assembled a critical mass of fibrosis expertise and a top-tier leadership team and world-class network of advisors with unparalleled experience in anti-fibrotic drug R&D. Blade ’s lead program is a small molecule...

HealthyChildrenToday.com

HealthyChildrenToday.com is committed to providing the latest and most relevant information for children with respiratory issues or compromised immune systems. Visitors can read the most recent articles on topics ranging from asthma and allergies to cystic fibrosis and premature infants. The site's Med Blog and MedTech Blog showcase commentary from concerned parents, technology researchers, and to...


Biotech Scotland

Biotechnology in Scotland

Fibrotech Therapeutics

Fibrotech is an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis (tissue scarring). The Company develops novel anti-fibrotic drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as chronic kidney disease, chronic heart failure, pulmonary fibros...

Scottish Biomedical

Established in 1994, Scottish Biomedical is a private, self-funded drug discovery services company located on the West of Scotland Science Park, Glasgow, Scotland. Our capabilities and expertise are in the areas of ethical tissue acquisition, molecular biology, protein technology, primary & secondary assay evelopment, high-throughput & high-content screening, medicinal chemistry and pharmacology.S...

Nanobiotix

NanoBio® Corp. is a privately held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccines derived from its patented NanoStat™ technology platform. The company’s lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fun...

Alcresta Therapeutics, Inc.

Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel enzyme-based products designed to treat gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency, which results in malabsorption common in cysti...

NanoLogix, Inc.

NanoLogix is a biotechnology company focused primarily on medical diagnostics. Its products offer accelerated detection and identification of microorganisms present in infectious and non-infectious human diseases, such as tuberculosis, NTM, pneumonia, HIV/AIDS, cancer, cystic fibrosis, anthrax, and plague. In addition to medical, Defense, and homeland security applications, NanoLogix technology is...

BRAX Fundraising

Launched in 2005, BRAX Fundraising has quickly been recognized as one of the fastest growing fundraising companies in America. Featuring more than 170 officially licensed products, BRAX Fundraising works with nonprofit organizations, including schools and youth sports organizations, to help them achieve their fundraising goals. BRAX is a proud sponsor of the Boomer Esiason Foundation to cure Cysti...

Retrophin, LLC

Retrophin, LLC is a privately-held New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for focal segmental glomerulosclerosis, Duchenne Muscular Dystrophy, spinal muscular atrophy, cystic fibrosis and myotubular myopathy. Retrophin's Seri...

Aradigm Corporation and Grifols S.A.

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. Aradigm has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and prevention of ...

Pulmatrix

Pulmatrix is discovering and developing a new class of therapies --inhaled cationic airway lining modulators (iCALM) –to prevent and treat respiratory infections and acute exacerbations of chronic respiratory diseases. iCALM therapies have broad potential to treat and prevent a wide range of respiratory diseases, including respiratory infections such ...

Good Start Genetics®, Inc.

GoodStart Select is Good Start Genetics’ menu of carrier screening tests that, for diseases such as cystic fibrosis, detects many more disease-causing mutations than any other routine carrier screening test, regardless of patient ethnicity. After years of development and rigorous validation, Good Start Genetics has harnessed the power of its sophistic...

BioIndustry Association

The BIA operates from central London facilities which are open daily and staffed by a permanent team. Our Chief Executive works with the BIA Secretariat to identify the needs of members, to agree with the Board a programme of activities to meet those needs, and to assist and implement the Board's strategic planning. BIA member companies range from the smallest start-up ventures to multinational ph...

Kennedys Patent

Kennedys Patent is a firm of Chartered Patent & Trademark Attorneys. Our business was built on the belief that Intellectual Property is viewed not in isolation, but is integral to the business strategy.Kennedys Patent, which set up only in 1997, now has a staff of 25, offices in Glasgow, Aberdeen and Newcastle and year on year growth of over 40%. It has a client list that boasts multinationals, i...

GenMark Diagnostics, Inc.

GenMark, a provider of automated, multiplex molecular diagnostic testing systems, detects and measures DNA and RNA targets to diagnose disease and to optimize the treatment of patients and is focused on developing and commercializing its eSensor detection technology. GenMark’s XT-8 System is designed to support a broad range of molecular diagnostic te...

NanoBio Corp.

NanoBio® Corporation is a privately-held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccines derived from its patented NanoStat® technology platform. The company’s lead product candidates are treatments for herpes labialis, onychomycosis, vaginitis, cystic...

Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics (PTI) is developing novel disease-modifying therapeutics that target the cellular pathways regulating protein folding, trafficking, and clearance. The Proteostasis Network (PN) is comprised of these interconnected cellular pathways and can become imbalanced by the cumulative effects of aging, disease, genetics and environmental fa...

Trucode Gene Repair

Trucode Gene Repair is advancing its novel triplex gene editing platform to potentially cure devastating genetic diseases, with initial focus on sickle cell disease and cystic fibrosis. The elegance of triplex gene editing lies in its ability to harness natural, high-fidelity DNA repair mechanisms, and its independence from the requirement for exogenous nucleases and viral vectors. Trucode is hea...

EPIX Pharmaceuticals

EPIX Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products through the use of proprietary technology to better diagnose, treat and manage patients. The company has five internally-discovered therapeutic and imaging drug candidates currently in clinical trials targeting conditions such as depression, Alzheimer's disease, ...

PTC Therapeutics Inc.

PTC THERAPEUTICS, INC. (PTC) is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC has assembled pro...

Mpex Pharmaceuticals, Inc.

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. The company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacte...

Galecto Biotech AB

Galectin-3 is a member of the galectin family of galactoside binding lectins. Galectin-3 exists both intra- and extracellularly and binds to glycosylated proteins. Galectin-3 has been shown to play a central role in fibrosis development and progression. The activation of macrophages, and recruitment and activation of myofibroblasts, the two central cell ty...

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded drug products and develops new medicines to treat patients suffering from diseases principally in five therapeutic areas: central nervous system, cardiovascular, gastrointestinal...


More From BioPortfolio on "Scotland provide year cystic fibrosis drug"

Quick Search

Corporate Database Quicklinks